Skip to main content
Top
Published in: Journal of Translational Medicine 1/2022

Open Access 01-12-2022 | Research

Targets preliminary screening for the fresh natural drug molecule based on Cosine-correlation and similarity-comparison of local network

Authors: Pengcheng Zhao, Lin Lin, Mozheng Wu, Lili Wang, Qi Geng, Li Li, Ning Zhao, Jianyu Shi, Cheng Lu

Published in: Journal of Translational Medicine | Issue 1/2022

Login to get access

Abstract

Background

Chinese herbal medicine is made up of hundreds of natural drug molecules and has played a major role in traditional Chinese medicine (TCM) for several thousand years. Therefore, it is of great significance to study the target of natural drug molecules for exploring the mechanism of treating diseases with TCM. However, it is very difficult to determine the targets of a fresh natural drug molecule due to the complexity of the interaction between drug molecules and targets. Compared with traditional biological experiments, the computational method has the advantages of less time and low cost for targets screening, but it remains many great challenges, especially for the molecules without social ties.

Methods

This study proposed a novel method based on the Cosine-correlation and Similarity-comparison of Local Network (CSLN) to perform the preliminary screening of targets for the fresh natural drug molecules and assign weights to them through a trained parameter.

Results

The performance of CSLN is superior to the popular drug-target-interaction (DTI) prediction model GRGMF on the gold standard data in the condition that is drug molecules are the objects for training and testing. Moreover, CSLN showed excellent ability in checking the targets screening performance for a fresh-natural-drug-molecule (scenario simulation) on the TCMSP (13 positive samples in top20), meanwhile, Western-Blot also further verified the accuracy of CSLN.

Conclusions

In summary, the results suggest that CSLN can be used as an alternative strategy for screening targets of fresh natural drug molecules.
Literature
1.
go back to reference Jiang M, Lu C, Chen G, Xiao C, Zha Q, Niu X, et al. Understanding the molecular mechanism of interventions in treating rheumatoid arthritis patients with corresponding traditional chinese medicine patterns based on bioinformatics approach. Evid Based Complement Alternat Med. 2012;2012:129452.PubMedPubMedCentral Jiang M, Lu C, Chen G, Xiao C, Zha Q, Niu X, et al. Understanding the molecular mechanism of interventions in treating rheumatoid arthritis patients with corresponding traditional chinese medicine patterns based on bioinformatics approach. Evid Based Complement Alternat Med. 2012;2012:129452.PubMedPubMedCentral
2.
go back to reference Mao X, Xu H, Li S, Su J, Li W, Guo Q, et al. Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network. Phytomedicine. 2019;54:159–68.CrossRef Mao X, Xu H, Li S, Su J, Li W, Guo Q, et al. Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network. Phytomedicine. 2019;54:159–68.CrossRef
3.
go back to reference Zhao N, Zheng G, Li J, Zhao HY, Lu C, Jiang M, et al. Text mining of rheumatoid arthritis and diabetes mellitus to understand the mechanisms of chinese medicine in different diseases with same treatment. Chin J Integr Med. 2018;24(10):777–84.CrossRef Zhao N, Zheng G, Li J, Zhao HY, Lu C, Jiang M, et al. Text mining of rheumatoid arthritis and diabetes mellitus to understand the mechanisms of chinese medicine in different diseases with same treatment. Chin J Integr Med. 2018;24(10):777–84.CrossRef
4.
go back to reference Cao DS, Liu S, Xu QS, Lu HM, Huang JH, Hu QN, et al. Large-scale prediction of drug-target interactions using protein sequences and drug topological structures. Anal Chim Acta. 2012;752:1–10.CrossRef Cao DS, Liu S, Xu QS, Lu HM, Huang JH, Hu QN, et al. Large-scale prediction of drug-target interactions using protein sequences and drug topological structures. Anal Chim Acta. 2012;752:1–10.CrossRef
5.
go back to reference Xu R, Wang Q. Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing. BMC Bioinform. 2013;14:181.CrossRef Xu R, Wang Q. Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing. BMC Bioinform. 2013;14:181.CrossRef
6.
go back to reference Alam F, Corazza A, Lavelli A, Zanoli R. A knowledge-poor approach to chemical-disease relation extraction. Database (Oxford). 2016;2016. Alam F, Corazza A, Lavelli A, Zanoli R. A knowledge-poor approach to chemical-disease relation extraction. Database (Oxford). 2016;2016.
7.
go back to reference Yang J, Li Z, Fan X, Cheng Y. Drug-disease association and drug-repositioning predictions in complex diseases using causal inference-probabilistic matrix factorization. J Chem Inf Model. 2014;54(9):2562–9.CrossRef Yang J, Li Z, Fan X, Cheng Y. Drug-disease association and drug-repositioning predictions in complex diseases using causal inference-probabilistic matrix factorization. J Chem Inf Model. 2014;54(9):2562–9.CrossRef
8.
go back to reference Zhao S, Li S. A co-module approach for elucidating drug-disease associations and revealing their molecular basis. Bioinformatics. 2012;28(7):955–61.CrossRef Zhao S, Li S. A co-module approach for elucidating drug-disease associations and revealing their molecular basis. Bioinformatics. 2012;28(7):955–61.CrossRef
9.
go back to reference Wang L, Wang Y, Hu Q, Li S. Systematic analysis of new drug indications by drug-gene-disease coherent subnetworks. CPT Pharmacometrics Syst Pharmacol. 2014;3:e146.CrossRef Wang L, Wang Y, Hu Q, Li S. Systematic analysis of new drug indications by drug-gene-disease coherent subnetworks. CPT Pharmacometrics Syst Pharmacol. 2014;3:e146.CrossRef
10.
go back to reference Bagherian M, Sabeti E, Wang K, Sartor MA, Nikolovska-Coleska Z, Najarian K. Machine learning approaches and databases for prediction of drug-target interaction: a survey paper. Brief Bioinform. 2021;22(1):247–69.CrossRef Bagherian M, Sabeti E, Wang K, Sartor MA, Nikolovska-Coleska Z, Najarian K. Machine learning approaches and databases for prediction of drug-target interaction: a survey paper. Brief Bioinform. 2021;22(1):247–69.CrossRef
11.
go back to reference Zhang W, Yue X, Huang F, Liu R, Chen Y, Ruan C. Predicting drug-disease associations and their therapeutic function based on the drug-disease association bipartite network. Methods. 2018;145:51–9.CrossRef Zhang W, Yue X, Huang F, Liu R, Chen Y, Ruan C. Predicting drug-disease associations and their therapeutic function based on the drug-disease association bipartite network. Methods. 2018;145:51–9.CrossRef
12.
go back to reference Chen X, Li TH, Zhao Y, Wang CC, Zhu CC. Deep-belief network for predicting potential miRNA-disease associations. Brief Bioinform. 2020;22(3):bbaa186.CrossRef Chen X, Li TH, Zhao Y, Wang CC, Zhu CC. Deep-belief network for predicting potential miRNA-disease associations. Brief Bioinform. 2020;22(3):bbaa186.CrossRef
13.
go back to reference Lee T, Yoon Y. Drug repositioning using drug-disease vectors based on an integrated network. BMC Bioinform. 2018;19(1):446.CrossRef Lee T, Yoon Y. Drug repositioning using drug-disease vectors based on an integrated network. BMC Bioinform. 2018;19(1):446.CrossRef
14.
go back to reference Lu Y, Guo Y, Korhonen A. Link prediction in drug-target interactions network using similarity indices. BMC Bioinform. 2017;18(1):39.CrossRef Lu Y, Guo Y, Korhonen A. Link prediction in drug-target interactions network using similarity indices. BMC Bioinform. 2017;18(1):39.CrossRef
15.
go back to reference Abdel-Basset M, Mohamed M, Elhoseny M, Son LH, Chiclana F, Zaied AEH. Cosine similarity measures of bipolar neutrosophic set for diagnosis of bipolar disorder diseases. Artif Intell Med. 2019;101:101735.CrossRef Abdel-Basset M, Mohamed M, Elhoseny M, Son LH, Chiclana F, Zaied AEH. Cosine similarity measures of bipolar neutrosophic set for diagnosis of bipolar disorder diseases. Artif Intell Med. 2019;101:101735.CrossRef
16.
go back to reference Cai S, Georgakilas GK, Johnson JL, Vahedi G. A cosine similarity-based method to infer variability of chromatin accessibility at the single-cell level. Front Genet. 2018;9:319.CrossRef Cai S, Georgakilas GK, Johnson JL, Vahedi G. A cosine similarity-based method to infer variability of chromatin accessibility at the single-cell level. Front Genet. 2018;9:319.CrossRef
17.
go back to reference Grieb N, Oltrup T, Bende T, Leitritz MA. The cosine similarity technique: a new method for smart EXCIMER laser control. Z Med Phys. 2020;30(4):253–8.CrossRef Grieb N, Oltrup T, Bende T, Leitritz MA. The cosine similarity technique: a new method for smart EXCIMER laser control. Z Med Phys. 2020;30(4):253–8.CrossRef
18.
go back to reference Ye J. Improved cosine similarity measures of simplified neutrosophic sets for medical diagnoses. Artif Intell Med. 2015;63(3):171–9.CrossRef Ye J. Improved cosine similarity measures of simplified neutrosophic sets for medical diagnoses. Artif Intell Med. 2015;63(3):171–9.CrossRef
19.
go back to reference Khalili H, Godwin A, Choi JW, Lever R, Brocchini S. Comparative binding of disulfide-bridged PEG-Fabs. Bioconjug Chem. 2012;23(11):2262–77.CrossRef Khalili H, Godwin A, Choi JW, Lever R, Brocchini S. Comparative binding of disulfide-bridged PEG-Fabs. Bioconjug Chem. 2012;23(11):2262–77.CrossRef
20.
go back to reference Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13.CrossRef Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13.CrossRef
21.
go back to reference Hou W, Liu B, Xu H. Triptolide: medicinal chemistry, chemical biology and clinical progress. Eur J Med Chem. 2019;176:378–92.CrossRef Hou W, Liu B, Xu H. Triptolide: medicinal chemistry, chemical biology and clinical progress. Eur J Med Chem. 2019;176:378–92.CrossRef
22.
go back to reference Taylor SC, Posch A. The design of a quantitative western blot experiment. Biomed Res Int. 2014;2014:361590.CrossRef Taylor SC, Posch A. The design of a quantitative western blot experiment. Biomed Res Int. 2014;2014:361590.CrossRef
23.
go back to reference Yamanishi Y, Araki M, Gutteridge A, Honda W, Kanehisa M. Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics. 2008;24(13):i232–40.CrossRef Yamanishi Y, Araki M, Gutteridge A, Honda W, Kanehisa M. Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics. 2008;24(13):i232–40.CrossRef
24.
go back to reference Bento AP, Hersey A, Felix E, Landrum G, Gaulton A, Atkinson F, et al. An open source chemical structure curation pipeline using RDKit. J Cheminform. 2020;12(1):51.CrossRef Bento AP, Hersey A, Felix E, Landrum G, Gaulton A, Atkinson F, et al. An open source chemical structure curation pipeline using RDKit. J Cheminform. 2020;12(1):51.CrossRef
25.
go back to reference Vogt M, Bajorath J. Modeling tanimoto similarity value distributions and predicting search results. Mol Inform. 2017;36:7.CrossRef Vogt M, Bajorath J. Modeling tanimoto similarity value distributions and predicting search results. Mol Inform. 2017;36:7.CrossRef
26.
go back to reference Zhang ZC, Zhang XF, Wu M, Ou-Yang L, Zhao XM, Li XL. A graph regularized generalized matrix factorization model for predicting links in biomedical bipartite networks. Bioinformatics. 2020;36(11):3474–81.CrossRef Zhang ZC, Zhang XF, Wu M, Ou-Yang L, Zhao XM, Li XL. A graph regularized generalized matrix factorization model for predicting links in biomedical bipartite networks. Bioinformatics. 2020;36(11):3474–81.CrossRef
27.
go back to reference Huang Y, Chen Z, Wang Y, Ba X, Huang Y, Shen P, et al. Triptolide exerts an anti-tumor effect on nonsmall cell lung cancer cells by inhibiting activation of the IL6/STAT3 axis. Int J Mol Med. 2019;44(1):291–300.PubMed Huang Y, Chen Z, Wang Y, Ba X, Huang Y, Shen P, et al. Triptolide exerts an anti-tumor effect on nonsmall cell lung cancer cells by inhibiting activation of the IL6/STAT3 axis. Int J Mol Med. 2019;44(1):291–300.PubMed
28.
go back to reference You L, Dong X, Ni B, Fu J, Yang C, Yin X, et al. Triptolide induces apoptosis through fas death and mitochondrial pathways in HepaRG Cell Line. Front Pharmacol. 2018;9:813.CrossRef You L, Dong X, Ni B, Fu J, Yang C, Yin X, et al. Triptolide induces apoptosis through fas death and mitochondrial pathways in HepaRG Cell Line. Front Pharmacol. 2018;9:813.CrossRef
29.
go back to reference Xu P, Berto S, Kulkarni A, Jeong B, Joseph C, Cox KH, et al. NPAS4 regulates the transcriptional response of the suprachiasmatic nucleus to light and circadian behavior. Neuron. 2021;109(20):3268–82.CrossRef Xu P, Berto S, Kulkarni A, Jeong B, Joseph C, Cox KH, et al. NPAS4 regulates the transcriptional response of the suprachiasmatic nucleus to light and circadian behavior. Neuron. 2021;109(20):3268–82.CrossRef
30.
go back to reference Wang HY, Taggi AE, Meinwald J, Wise RA, Woods AS. Study of the interaction of chlorisondamine and chlorisondamine analogues with an epitope of the alpha-2 neuronal acetylcholine nicotinic receptor subunit. J Proteome Res. 2005;4(2):532–9.CrossRef Wang HY, Taggi AE, Meinwald J, Wise RA, Woods AS. Study of the interaction of chlorisondamine and chlorisondamine analogues with an epitope of the alpha-2 neuronal acetylcholine nicotinic receptor subunit. J Proteome Res. 2005;4(2):532–9.CrossRef
31.
go back to reference Qi B, Wang X, Zhou Y, Han Q, He L, Gong T, et al. A renal-targeted triptolide aminoglycoside (TPAG) conjugate for lowering systemic toxicities of triptolide. Fitoterapia. 2015;103:242–51.CrossRef Qi B, Wang X, Zhou Y, Han Q, He L, Gong T, et al. A renal-targeted triptolide aminoglycoside (TPAG) conjugate for lowering systemic toxicities of triptolide. Fitoterapia. 2015;103:242–51.CrossRef
32.
go back to reference Xi C, Peng S, Wu Z, Zhou Q, Zhou J. Toxicity of triptolide and the molecular mechanisms involved. Biomed Pharmacother. 2017;90:531–41.CrossRef Xi C, Peng S, Wu Z, Zhou Q, Zhou J. Toxicity of triptolide and the molecular mechanisms involved. Biomed Pharmacother. 2017;90:531–41.CrossRef
33.
go back to reference Long DJ 2nd, Jaiswal AK. NRH:quinone oxidoreductase2 (NQO2). Chem Biol Interact. 2000;129(1–2):99–112.CrossRef Long DJ 2nd, Jaiswal AK. NRH:quinone oxidoreductase2 (NQO2). Chem Biol Interact. 2000;129(1–2):99–112.CrossRef
Metadata
Title
Targets preliminary screening for the fresh natural drug molecule based on Cosine-correlation and similarity-comparison of local network
Authors
Pengcheng Zhao
Lin Lin
Mozheng Wu
Lili Wang
Qi Geng
Li Li
Ning Zhao
Jianyu Shi
Cheng Lu
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2022
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-022-03279-w

Other articles of this Issue 1/2022

Journal of Translational Medicine 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.